TY - JOUR
T1 - Standardized Data Elements for Patients With Acute Pulmonary Embolism
T2 - A Consensus Report From the Pulmonary Embolism Research Collaborative
AU - Pulmonary Embolism Research Collaborative (PERC) Attendees
AU - Rosenfield, Kenneth
AU - Bowers, Terry R.
AU - Barnett, Christopher F.
AU - Davis, George A.
AU - Giri, Jay
AU - Horowitz, James M.
AU - Huisman, Menno V.
AU - Hunt, Beverley J.
AU - Keeling, Brent
AU - Kline, Jeffrey A.
AU - Klok, Frederikus A.
AU - Konstantinides, Stavros V.
AU - Lanno, Michelle T.
AU - Lookstein, Robert
AU - Moriarty, John M.
AU - Ní Áinle, Fionnuala
AU - Reed, Jamie L.
AU - Rosovsky, Rachel P.
AU - Royce, Sara M.
AU - Secemsky, Eric A.
AU - Sharp, Andrew S.P.
AU - Sista, Akhilesh K.
AU - Smith, Roy E.
AU - Wells, Phil
AU - Yang, Joanna
AU - Whatley, Eleni M.
N1 - Publisher Copyright:
© 2024 American Heart Association, Inc.
PY - 2024/10/1
Y1 - 2024/10/1
N2 - Recent advances in therapy and the promulgation of multidisciplinary pulmonary embolism teams show great promise to improve management and outcomes of acute pulmonary embolism (PE). However, the absence of randomized evidence and lack of consensus leads to tremendous variations in treatment and compromises the wide implementation of new innovations. Moreover, the changing landscape of health care, where quality, cost, and accountability are increasingly relevant, dictates that a broad spectrum of outcomes of care must be routinely monitored to fully capture the impact of modern PE treatment. We set out to standardize data collection in patients with PE undergoing evaluation and treatment, and thus establish the foundation for an expanding evidence base that will address gaps in evidence and inform future care for acute PE. To do so, >100 international PE thought leaders convened in Washington, DC, in April 2022 to form the Pulmonary Embolism Research Collaborative. Participants included physician experts, key members of the US Food and Drug Administration, patient representatives, and industry leaders. Recognizing the multidisciplinary nature of PE care, the Pulmonary Embolism Research Collaborative was created with representative experts from stakeholder medical subspecialties, including cardiology, pulmonology, vascular medicine, critical care, hematology, cardiac surgery, emergency medicine, hospital medicine, and pharmacology. A list of critical evidence gaps was composed with a matching comprehensive set of standardized data elements; these data points will provide a foundation for productive research, knowledge enhancement, and advancement of clinical care within the field of acute PE, and contribute to answering urgent unmet needs in PE management. Evidence produced through the Pulmonary Embolism Research Collaborative, as it is applied to data collection, promises to provide crucial knowledge that will ultimately produce a robust evidence base that will lead to standardization and harmonization of PE management and improved outcomes.
AB - Recent advances in therapy and the promulgation of multidisciplinary pulmonary embolism teams show great promise to improve management and outcomes of acute pulmonary embolism (PE). However, the absence of randomized evidence and lack of consensus leads to tremendous variations in treatment and compromises the wide implementation of new innovations. Moreover, the changing landscape of health care, where quality, cost, and accountability are increasingly relevant, dictates that a broad spectrum of outcomes of care must be routinely monitored to fully capture the impact of modern PE treatment. We set out to standardize data collection in patients with PE undergoing evaluation and treatment, and thus establish the foundation for an expanding evidence base that will address gaps in evidence and inform future care for acute PE. To do so, >100 international PE thought leaders convened in Washington, DC, in April 2022 to form the Pulmonary Embolism Research Collaborative. Participants included physician experts, key members of the US Food and Drug Administration, patient representatives, and industry leaders. Recognizing the multidisciplinary nature of PE care, the Pulmonary Embolism Research Collaborative was created with representative experts from stakeholder medical subspecialties, including cardiology, pulmonology, vascular medicine, critical care, hematology, cardiac surgery, emergency medicine, hospital medicine, and pharmacology. A list of critical evidence gaps was composed with a matching comprehensive set of standardized data elements; these data points will provide a foundation for productive research, knowledge enhancement, and advancement of clinical care within the field of acute PE, and contribute to answering urgent unmet needs in PE management. Evidence produced through the Pulmonary Embolism Research Collaborative, as it is applied to data collection, promises to provide crucial knowledge that will ultimately produce a robust evidence base that will lead to standardization and harmonization of PE management and improved outcomes.
KW - data collection
KW - multidisciplinary care team
KW - percutaneous aspiration
KW - pulmonary embolism
KW - registry data
KW - standardization
KW - thrombectomy
KW - thrombolytic therapy
UR - https://www.scopus.com/pages/publications/85205061225
U2 - 10.1161/CIRCULATIONAHA.124.067482
DO - 10.1161/CIRCULATIONAHA.124.067482
M3 - Review article
C2 - 39263752
AN - SCOPUS:85205061225
SN - 0009-7322
VL - 150
SP - 1140
EP - 1150
JO - Circulation
JF - Circulation
IS - 14
ER -